Roeker, LE, Eyre, TA, Thompson, MC, Lamanna, N, Coltoff, AR, Davids, MS, Baker, PO
, Leslie, L, Rogers, KA, Allan, JN, Cordoba, R, Lopez-Garcia, A, Antic, D, Pagel, JM, Martinez-Calle, N, García-Marco, JA, Hernández-Rivas, JÁ, Miras, F, Coombs, CC, Österborg, A, Hansson, L, Seddon, AN, López Jiménez, J, Wilson, MR, El-Sharkawi, D, Wojenski, D, Ma, S, Munir, T, Valenciano, S, Seymour, E, Barr, PM, Pu, J, Patten, PEM, Perini, GF, Huntington, SF, Parry, H, Sundaram, S, Skarbnik, A, Kamdar, M, Jacobs, R, Walter, H, Walewska, R, Broom, A, Lebowitz, S, Isaac, KM, Portell, CA, Ahn, IE, Ujjani, CS, Shadman, M, Skånland, S, Chong, EA & Mato, AR 2021, '
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies',
Blood, vol. 138, no. 18, pp. 1768-1773.
https://doi.org/10.1182/blood.2021011841